施圣兵
作品数: 3被引量:12H指数:2
  • 所属机构:江苏大学附属医院
  • 所在地区:江苏省 镇江市
  • 研究方向:医药卫生

相关作者

俞力超
作品数:66被引量:215H指数:7
供职机构:江苏大学附属医院
研究主题:食管癌 非小细胞肺癌 超声提取 食管肿瘤 食管鳞癌
张德厚
作品数:65被引量:298H指数:9
供职机构:江苏大学附属医院
研究主题:无创正压通气 呼吸衰竭 脓毒症 救治 急性呼吸衰竭
蒋雄斌
作品数:35被引量:162H指数:7
供职机构:江苏省人民医院
研究主题:急性肺损伤 呼吸道合胞病毒 干扰素-Γ T辅助淋巴细胞 雷公藤多甙
郭昭扬
作品数:21被引量:118H指数:6
供职机构:江苏大学附属医院
研究主题:食管肿瘤 食管癌 预后 淋巴结转移 外科治疗
丁明
作品数:38被引量:163H指数:8
供职机构:江苏大学附属医院
研究主题:无创正压通气 呼吸衰竭 救治 急性呼吸衰竭 无创正压通气治疗
晚期自发性食管破裂的治疗被引量:2
2003年
目的 探讨晚期自发性食管破裂的治疗方法选择。方法 回顾性分析 11例晚期自发性食管破裂的治疗过程 ,其中非手术治疗 1例 ,手术治疗 10例。对手术治疗者根据不同的全身及局部情况采用了 5种不同术式 ,并高度重视全身治疗。结果 行一期手术 8例、二期手术 2例 ,术后发生颈部吻合口瘘 1例、胸部慢性窦道 1例。非手术治疗 1例未愈 ,死亡。结论 合理的术式选择和积极的全身治疗可以提高晚期自发性食管破裂的疗效。
施圣兵俞力超郭昭扬徐新华
关键词:手术疗法非手术疗法晚期自发性食管破裂手术方式食管修补术
食管癌术后急性呼吸衰竭的临床特点及危险因素被引量:10
2004年
目的 :分析食管癌术后急性呼吸衰竭 (ARF)的临床特点及危险因素。方法 :对 1999年 1月至 2 0 0 3年 6月住院治疗的 4 95例食管癌术后患者的临床资料作回顾性分析。结果 :4 95例食管癌术后 2 9例发生ARF。Logistic回归分析发现患者高龄、长期吸烟、营养不良、术前呼吸功能减退、手术时间长及术后胸部并发症是发生术后ARF的危险因素。结论 :食管癌术后发生ARF是由多种因素相互作用的结果 ,避免食管癌术后ARF的危险因素是预防术后ARF的关键。
蒋雄斌张烨青施圣兵
关键词:食管癌胸部手术急性呼吸衰竭ARF肿瘤
Prognostic Impact of Histopathologic Response after Neoadjuvant Chemotherapy in Stage Ⅲ_A Non-small Cell Lung Cancer
2006年
Objective: To investigate prognostic impact of histopathologic response induced by neoadjuvant chemotherapy in patients with stage ⅢA non-small cell lung cancer (NSCLC). Methods: Forty patients with stage ⅢA NSCLC underwent two cycles of neoadjuvant chemotherapy with mitomycin, vindosine, and cisplatin followed by surgery. Histopathologic response in resection of the tumor was examined after surgery. Tumor regression was classified as grade Ⅳ, grade Ⅲ, grade Ⅱ, and grade Ⅰ according to the extent of tumor necrosis and the extent of the vital tumor tissues. The tumor regression grading was correlated with the survival time of the patients. Results: After two cycles of chemotherapy, 19 (47.5%) of 40 patients had objective response (2 complete and 17 partial response). In 40 resected tumor specimens, 2 (5%) were classified as regression grade Ⅳ, 16 (40%) as regression grade Ⅲ, 18 (45%) as regression gradeⅡ, and 4 (10%) as regression grade Ⅰ. The rate of complete surgical resection was significantly higher in patients with tumor regression grade Ⅲ-Ⅳ (〈10% vital tumor tissue)(P〈0.05). The median survival time in patients classified as having tumor regression grade Ⅲ-Ⅳ was significantly longer than that in patients who had regression grade Ⅰ-Ⅱ (P〈0.05). The 3-year survival rate in patients with regression grade Ⅲ-Ⅳ was markedly higher than that in patients who had regression grade Ⅰ-Ⅱ (P〈0.05). Conclusion: The extent of tumor regression induced by neoadjuvant chemotherapy is a critical issue for successful therapeutic approach in patients with stage ⅢA NSCLC. In resected specimens of tumors after chemotherapy, the presence of marked tumor regression (regression grade Ⅲ-Ⅳ) is predictive for superior survival time.
李坚吴建农仇灏俞力超张德厚施圣兵丁明
关键词:SURVIVAL